Replies to post #3187 on Revance Therapeutics Inc (RVNC)

[vinmantoo]

the way to make real money in biotech is to invest in companies with solid science and good management and then hold long term through all the bone-jarring volatility.

That is my methodology too. I bought more RVNC yesterday at $26.40. I assumed RVNC was dropping after its big jump last week due to profit taking. I mistakenly thought the CPI data would be out today and assumed it would show slowed inflation, as it did, and I would be able to buy more RVNC before that data was released. Fortunately for me the market didn't react so quickly to the excellent inflation data and I was able to at the aforementioned price.

After 2 decades of investing I have finally learned to accept or even embrace the wild market swings as they provide buying and selling opportunities to those who don't panic or don't get too greedy. I will probably stop buying RVNC as it has now jumped over EXEL in my portfolio to be come my second largest holding and I am sitting on a 50% paper gain. I need a bit more diversification in my biotech portfolio.

[jmkobers]

3 times to add/open a position last 3-4 years:
-after Browne left and Foley became CEO. Pps was down daily for months prior, bottomed in 10's in spring/summer of '19 before peaking in 20's in '20
-after failed inspection Oct '21, on sale from mid 12's up
-short raid just recently - brought pps into low 18's prior to short squeeze, +50% 1/9/23

If you didn't add or open at any (and at the time there was perceived risk adding/opening for all three, both micro & macro), you are most likely nowhere in terms of making money, (considering opportunity costs lost probably down), because it's been hoeing the same ground ad nauseam in between the 3 big dips after recoveries. Needs to break 30. When/if it does, it can run finally, and I think it eventually will fairly soon